The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbingdon Healt. Share News (ABDX)

Share Price Information for Abingdon Healt. (ABDX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11.00
Bid: 10.50
Ask: 11.50
Change: 0.00 (0.00%)
Spread: 1.00 (9.524%)
Open: 11.00
High: 11.00
Low: 11.00
Prev. Close: 11.00
ABDX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Stocks lower; Sunak looks to sell protocol deal

Tue, 28th Feb 2023 12:03

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday, as investors wait to hear whether UK Prime Minister Rishi Sunak has been able to win support for his Northern Irish border deal with the EU.

The FTSE 100 index was down 27.93 points, 0.4%, at 7,907.18 heading into Tuesday afternoon. The FTSE 250 was down 22.90 points, 0.1%, at 19,863.20, though the AIM All-Share was up 1.07 points, 0.1%, at 859.54.

The Cboe UK 100 was down 0.4% at 791.35, the Cboe UK 250 was up marginally at 17,433.50, and the Cboe Small Companies was down 0.1% at 14,060.42.

Sunak insisted that his new Brexit deal for Northern Ireland addressed the concerns of unionists, despite the "small and limited" role for EU law and its court.

The PM, who was visiting Northern Ireland to sell the deal secured with the EU, said he believed "hand on heart" that it addressed the concerns expressed about the current post-Brexit trading arrangements which triggered the collapse of power-sharing in Stormont.

The Democratic Unionist Party, which brought down the Northern Ireland executive over the measures, is considering its response to the new deal.

The framework removes the Northern Ireland Protocol's barriers on trade across the Irish Sea and hands a "veto" to politicians in Stormont on EU law – a set of concessions from Brussels that went further than some expected.

"While the deal may provide a reset for UK/EU relations and be good for the UK economy, reports suggest some in the DUP are not fully satisfied by what's on the table," said AJ Bell analyst Russ Mould.

Sunak, who is also expected to speak to backbench MPs in England on Tuesday, spoke at length in the Commons on the deal as he sought to see off any threat of rebellion from within his own ranks.

MPs are expected to get a vote on the deal, but Downing Street has not so far said when or how such a vote might take place.

The pound was quoted at USD1.2093 at midday on Tuesday in London, up compared to USD1.2019 at the equities close on Monday. The euro stood at USD1.0611, up against USD1.0591. Against the yen, the dollar was trading at JPY136.72, up compared to JPY136.24.

UK Bank of England Monetary Policy Committee member Catherine Mann and Chief Economist Huw Pill will each speak at around 1230 GMT.

On the LSE, Ocado hurt the FTSE 100 index, slumping 8.3%.

The online grocer and warehouse technology firm said group revenue edged up just 0.6% to GBP2.51 billion in the year ended November 27. All segments saw growth, except for retail - its joint venture with Marks & Spencer - which fell 3.8%. "Robust" customer growth in retail was offset by lower value baskets, the firm said.

Ocado's pretax loss widened to GBP500.8 million from GBP176.9 million. No dividend was declared, unchanged from a year before.

Looking ahead, Ocado expects Retail growth in the mid-single digits for 2023, with Technology to see around 40% Ocado Smart Platform fee revenue growth, and UK Logistics to be "broadly stable".

AJ Bell's Mould said: "The latest results are as appetising as a bucket of sick. Revenue growth has ground to a halt, pretax losses are getting worse and net debt has ballooned.

"Ocado has long argued that it needs to spend money to make money, but patience is wearing thin for the long-suffering shareholders."

However, the firm's grocery market share improved to 1.9% from 1.8% in the 12 weeks to February 19, according to the latest Kantar survey. Ocado sales grew by 11% on-year.

Grocery inflation hit a record of 17.1% in the four weeks to February 19, according to Kantar. This means the average UK household is likely to see an GBP811 increase to their annual bill if inflation continues at the same pace.

Croda International also hurt the FTSE 100, shedding 4.4%.

The Yorkshire, England-based chemicals maker said sales rose 11% year-on-year to GBP2.09 billion in 2022 from GBP1.89 billion a year earlier. Constant currency sales rose by 5.0%, driven by "its ability to recover input cost inflation, with price/mix up by 24%."

Pretax profit surged 90% to GBP780.0 million from GBP411.5 million, as basic earnings per share jumped to 465.8 pence from 230.0p a year ago.

Croda lifted its annual dividend by 8.0% to 108.0 pence per share from 100.0p a year prior.

Looking to 2023, it is trading in line with expectations, and expects destocking to end during the first half. It said it expects its performance to be weighted towards the second half, putting pressure on its future performance.

"Investors hate hearing that phrase as it raises the chances of a profit warning if that six-month period doesn't live up to expectations," Mould added.

In the FTSE 250, Man Group gained 7.9%.

The London-based hedge fund manager said pretax profit in 2022 jumped 25% to USD608 million from USD487 million in 2021. Assets under management fell 3.6% to USD143.3 billion from USD148.6 billion, however.

The company declared a 2022 dividend of 15.7 cents, up 12% from 14.0 a year prior.

Meanwhile, Chair John Cryan will retire from the board "towards the end of 2023". Non-Executive Director Anne Wade will replace Cryan after his departure.

On London's AIM market, Abingdon Health gained 26%.

The developer and manufacturer of rapid diagnostics tests said it expects revenue to increase significantly in its second half, with annual revenue to improve from GBP2.8 million in financial 2022.

Revenue for the six months to December came in at GBP1.1 million, down from GBP1.7 million.

"The company has successfully transitioned its activities away from Covid-19 and is now operating as a fully integrated [contract development & manufacturing organisation] maintaining its full focus on lateral flow testing," the firm explained.

Safestay also jumped 26%.

The hostel owner and operator said annual revenue in 2022 will come in ahead of market expectations at GBP19.0 million, up from GBP6.4 million in 2021. Adjusted earnings before interest, tax, depreciation and amortisation are expected to be in line with market expectations at GBP5.9 million, swinging from a GBP1.0 million loss.

It said business is "returning to normal" with guests being predominantly young travellers, as group bookings are seeing a slower recovery. Average bed rate increases to GBP23.70 from GBP19.70, which should be "sustainable", the firm noted.

In European equities on Tuesday, the CAC 40 in Paris was flat, while the DAX 40 in Frankfurt was up 0.1%.

Growth in the French economy slowed in the final quarter of 2022, final data released on Tuesday confirmed, but it avoided contraction.

According to Insee - France's national statistics body - gross domestic product in the fourth quarter grew by 0.1% from the third quarter. In the third quarter, it had grown by 0.2% from the second.

Insee also released preliminary data for consumer prices.

In February 2023, consumer prices should increase by 6.2% year-on-year, quickening from growth of 6.0% in January.

Also putting the European Central Bank under the spotlight, figures showed inflation in Spain also intensified in February, suggesting that price pressure is proving stickier than ideal.

According to INE, the yearly inflation rate in Spain quickened to 6.1% in February, from 5.9% in January.

Stocks in New York were called lower. The Dow Jones Industrial Average, the S&P 500 index, and the Nasdaq Composite were all called down 0.2%.

Brent oil was quoted at USD83.11 a barrel at midday in London on Tuesday, up from USD82.28 late Monday. Gold was quoted at USD1,810.53 an ounce, down against USD1,816.96.

Still to come in Tuesday's economic calendar, there will be a US consumer confidence reading at 1500 GMT.

By Sophie Rose, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
7 Oct 2022 11:05

AIM WINNERS & LOSERS: Ince rises; Image Scan extends losses

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
7 Oct 2022 10:43

Abingdon Health shares jump as expects judgement on trial against DHSC

(Alliance News) Abingdon Health PLC on Friday said it expects a judgement by the UK's Technology & Construction Court in relation to the judicial review against the UK's Department of Health & Social Care at 1500 BST on Friday.

Read more
7 Oct 2022 08:46

LONDON MARKET OPEN: European markets tread water ahead of US jobs data

(Alliance News) - Stock prices in London opened mixed, as less-than-positive local economic data unnerved investors ahead of a critical US jobs print.

Read more
15 Aug 2022 11:11

Abingdon Health shares plummet as revenue falls and uncertainty looms

(Alliance News) - Shares in Abingdon Health PLC tumbled on Monday after the lateral flow test maker shared a disappointing update on its annual performance.

Read more
15 Aug 2022 10:53

Abingdon expects 'substantial' loss after disappointing year

(Sharecast News) - Rapid medical test developer Abingdon Health described a "disappointing" full-year performance in a trading update on Monday, with revenues expected to be in the region of £2.8m, and a "substantial loss" anticipated.

Read more
21 Jul 2022 22:01

TRADING UPDATES: Polymetal output falls; eEnergy revenue surges

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
11 Jul 2022 14:14

IN BRIEF: Omega Diagnostics shares jump on Abingdon Health payment

Omega Diagnostics Group PLC - Alva, Scotland-based diagnostics company - Says it has received an undisclosed payment from Abingdon Health PLC in relation to the manufacture and supply of AbC-19 Rapid tests, a Covid-19 lateral flow antibody test.

Read more
7 Jul 2022 20:41

IN BRIEF: Abingdon Health confirms payment from UK DHSC received

Abingdon Health PLC - York-based lateral flow test maker - Says it has received the GBP6.3 million cash payment from UK Department for Health & Social Care as part of the settlement agreement. Last month, the group reached a settlement with the DHSC on the outstanding invoices due from DHSC to Abingdon.

Read more
28 Jun 2022 12:21

Abingdon Health to receive GBP8.9 million from UK government

(Alliance News) - Shares in Abingdon Health PLC soared on Tuesday, as it said it reached a GBP8.9 million settlement agreement with the UK Department for Health & Social Care.

Read more
28 Jun 2022 11:26

AIM WINNERS & LOSERS: Abingdon up on settlement; Jangada needs funding

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
28 Jun 2022 11:19

Abingdon Health reaches £6.3m settlement with DHSC

(Sharecast News) - Rapid testing kits manufacturer Abingdon Health has reached a settlement agreement with the Department for Health and Social Care on outstanding invoices payable to the group for lateral flow tests and component stock.

Read more
6 Jun 2022 15:44

TRADING UPDATES: Avation extends easyJet lease; Abingdon wins deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
30 May 2022 18:29

TRADING UPDATES: UKOG signs lease; Alien Metals to buy Vivash Gorge

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
17 May 2022 12:51

Abingdon Health wins 'significant' rapid Covid test contract

(Sharecast News) - Rapid test developer and manufacturer Abingdon Health announced a "significant contract" with a European customer on Friday, for the production of lateral flow device (LFD) components for a Covid-19 antigen test.

Read more
17 May 2022 11:18

AIM WINNERS & LOSERS: Abingdon signs contract; Smartspace loss widens

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.